NJ S2212 | 2020-2021 | Regular Session
Note: Carry Over of previous A3525
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on March 16 2020 - 25% progression, died in committee
Action: 2020-03-16 - Introduced in the Senate, Referred to Senate Commerce Committee
Pending: Senate Commerce Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on March 16 2020 - 25% progression, died in committee
Action: 2020-03-16 - Introduced in the Senate, Referred to Senate Commerce Committee
Pending: Senate Commerce Committee
Text: Latest bill text (Introduced) [HTML]
Summary
"Prescription Drug Consumer Transparency Act."
Title
"Prescription Drug Consumer Transparency Act."
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2020-03-16 | Senate | Introduced in the Senate, Referred to Senate Commerce Committee |
Same As/Similar To
A3603 (Same As) 2020-03-05 - Introduced, Referred to Assembly Consumer Affairs Committee
A3525 (Carry Over) 2018-03-05 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
A3525 (Carry Over) 2018-03-05 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Subjects
New Jersey State Sources
| Type | Source |
|---|---|
| Summary | https://www.njleg.state.nj.us/bill-search/2020/S2212 |
| Text | https://pub.njleg.gov/Bills/2020/S2500/2212_I1.HTM |
